New ALK CEO on strategy review: "It's not about changing the goals"
ALK CEO Peter Halling states that the company’s goal remains to achieve an EBIT margin of around 25% by 2025.
On Thursday, Peter Halling was able to publish his second annual report as CEO of the listed allergy company ALK after taking up the position at the beginning of November last year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
ALK reports significantly improved operating profit
For subscribers
